All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma.

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Multiple Myeloma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Multiple Myeloma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Multiple Myeloma Hub cannot guarantee the accuracy of translated content. The Multiple Myeloma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.

The Multiple Myeloma Hub is an independent medical education platform, sponsored by Bristol Myers Squibb, GSK, Pfizer, Roche and Sanofi. The levels of sponsorship listed are reflective of the amount of funding given. Digital educational resources delivered on the Multiple Myeloma Hub are supported by an educational grant from Janssen Biotech, Inc. View funders.

Introducing

Enhance your learning with multiple myeloma content that's most relevant to you

Now you can create a space on the Multiple Myeloma Hub with specific content to help support your continued medical education in multiple myeloma.

This significant update brings several new features to enhance your experience across the website. The latest update includes a personalised dashboard for you to save, organize and access your favourite articles, videos, and enduring educational content. You can now bookmark your preferred educational content, select your specific areas of interest, and view content that is recommended for you based on your areas of interest and recently read articles.

To unlock these great new features, create your free user account with just a few simple steps.

Bookmark articles

Your latest bookmarked content can be found under the 'My bookmarked articles' section of your user dashboard. Click the 'bookmark this article' button, found at the top of any article to bookmark, alternatively click the bookmark icon shown alongside a content summary to save for later reading.

Specify your areas of interest

Select a trial, congress, or any relevant disease areas found across the site, to add an item to the 'Areas of interest' section, this content will also be used to suggest further recommendations. Areas of interest are easily edited using the 'Edit Intrests' button at the top of the page. Click any existing label to remove the item or add additional recommendations from the box below.

Read content recommended just for you

Your 'My Multiple Myeloma Hub' dashboard will display the latest bookmarked content; to view your full bookmark library, click the 'View More' button or 'My Bookmarked Articles' found under the account navigation dropdown.

To unlock these great features, create your free user account now

Create your user account to personalize your Multiple Myeloma Hub experience and gain access to a range of features designed to help you stay informed about multiple myeloma and enhance your multiple myeloma education.

If you have any queries or feedback, please don't hesitate to contact our team. We're here to help you make the most of the Multiple Myeloma Hub.